Healthcare
Real Brands, Inc.(RLBD)
Live Price
Offline$0.00001
+0.00% today
1Y Change
-90.00%
Window
Jun 20, 2025 โ Jun 12, 2026
- Market Cap
- โ
- Revenue Growth
- +443.0%
- EPS Growth
- -66.7%
- Dividend Yield
- 0.0%
Coverage: 247 bars ยท Jun 20, 2025 โ Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Real Brands, Inc. (RLBD) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and down 90.0% across the available one-year price window (Jun 20, 2025 โ Jun 12, 2026). Baseline metrics include revenue growth of +443.0%, EPS growth of -66.7%, a dividend yield of 0.0%. What stands out right now is revenue +443.0%, EPS -66.7%, free cash flow +74.1% with operating margin -1970.1% and ROIC 481.7%. Valuation is more restrained than many high-expectation growth names at price/sales 0.4. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines RLBD price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+443.0% vs +7.6% peer median
Operating Margin
Below sector median
-1970.1% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2025 was reported on Jun 19, 2025, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at +443.0% and EPS is at -66.7%, with operating margin around -1970.1%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2025 Jun 19, 2025 | โ | +0.0% | +0.0% | +0.0% |
2025 May 30, 2025 | โ | +0.0% | +0.0% | +0.0% |
2025 Feb 12, 2025 | โ | +0.0% | +0.0% | +0.0% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RLBD
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
RLBD Max Drawdown
-90.00%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for RLBD and SPY.
Company Overview
Real Brands, Inc.
Other OTC
Real Brands, Inc. engages in the extraction of hemp cannabinol (CBD) oil/isolate, wholesale of CBD oils and isolate, and production and sale of hemp-derived CBD products. It offers topical creams and gels, cosmetics, tinctures, oils, capsules, vape cartridges, oral sprays, lotions, and other products. The company was founded in 2011 and is headquartered in North Providence, Rhode Island.
- Leadership
- Thomas Kidrin
- IPO Date
- Nov 22, 2000
- Employees
- 1
- Street Address
- 12 Humbert Street
- Mailing
- North Providence, RI, 02991
- Region
- North Providence, RI, US
- Reporting Currency
- USD
- Investor Line
- 617 803 0004
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 0.4
- Price/Book
- โ
Growth
- Revenue
- +443.0%
- EPS
- -66.7%
- Free Cash Flow
- +74.1%
Profitability
- Gross Margin
- -41.6%
- Operating Margin
- -1970.1%
- Net Margin
- -2203.4%
- ROE
- 129.5%
- ROIC
- 481.7%
Balance Sheet
- Debt/Equity
- โ
- Current Ratio
- 0.03
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.